« Back to Record
Citation APA

Radwanska, M., de Lemos Esteves, F., Linsen, L., Coltel, N., Cencig, S., Widart, J. J., Massart, A., Colson, S., Di Paolo, A., Percier, P., Ait Djebbara, S., Guillonneau, F., Flamand, V., De Pauw, E., Frere, J.-L., Carlier, Y., & Truyens (Co-dernier auteur), C. (2023). Macrophage-infectivity potentiator of Trypanosoma cruzi (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in mice. Frontiers in immunology, 14, 1138526. doi:10.3389/fimmu.2023.1138526


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/363811

Radwanska, M., de Lemos Esteves, F., Linsen, L., Coltel, N., Cencig, S., Widart, J. J., Massart, A., Colson, S., Di Paolo, A., Percier, P., Ait Djebbara, S., Guillonneau, F., Flamand, V., De Pauw, E., Frere, J.-L., Carlier, Y., & Truyens (Co-dernier auteur), C. (2023). Macrophage-infectivity potentiator of Trypanosoma cruzi (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in mice. Frontiers in immunology, 14, 1138526. doi:10.3389/fimmu.2023.1138526